Human epidermal growth factor receptor-2 expression in locally advanced rectal cancer: Association with response to neoadjuvant therapy and prognosis

The aim of this study was to determine whether pretreatment status of human epidermal growth factor receptor-2 (HER-2) could predict pathologic response to neoadjuvant chemoradiotherapy (nCRT) and outcomes for patients with locally advanced rectal cancer (LARC). A total of 119 patients diagnosed wit...

Descripción completa

Detalles Bibliográficos
Autores principales: Meng, Xiangjiao, Wang, Renben, Huang, Zhaoqin, Zhang, Jianbo, Feng, Rui, Xu, Xiaoqing, Zhu, Kunli, Dou, Xue, Chen, Dong, Yu, Jinming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2014
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4317932/
https://www.ncbi.nlm.nih.gov/pubmed/24730770
http://dx.doi.org/10.1111/cas.12421

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4317932/
https://www.ncbi.nlm.nih.gov/pubmed/24730770
http://dx.doi.org/10.1111/cas.12421

Ejemplares similares